NUCLEAR SCIENCE
Latest Headlines
IRAN FIRST
Iranian company develops Tilmanocept radiopharmaceutical for cancer diagnosis
The product is in the final stages of clinical trials and will be commercialized by the end of this year.
The product is in the final stages of clinical trials and will be commercialized by the end of this year.
This makes it easy to access the Press TV website